Chris Tyler (@chrisjtyler) 's Twitter Profile
Chris Tyler

@chrisjtyler

VTE Commercial Leader🩸| Girl Dad 👨‍👩‍👧 | Skier⛷ | 26.2🏃‍♂️ | Mediocre Golfer ⛳️ Opinions are my own & not the views of my employer

ID: 1106670806283620352

calendar_today15-03-2019 21:37:35

1,1K Tweet

497 Followers

1,1K Following

Inari Medical (@inarimedical) 's Twitter Profile Photo

The all-new #VenaCore thrombectomy catheter is the only mechanical thrombectomy device specifically designed to address challenging venous occlusions associated with RVO, a common complication of #DVT. #VenaCore has shown early success in achieving significant luminal gain by

The all-new #VenaCore thrombectomy catheter is the only mechanical thrombectomy device specifically designed to address challenging venous occlusions associated with RVO, a common complication of #DVT.

#VenaCore has shown early success in achieving significant luminal gain by
Inari Medical (@inarimedical) 's Twitter Profile Photo

Congratulations to Dr. Nicole Ilonzo for publishing the FIRST EVER (and only) retrospective study on the #InThrill Thrombectomy System for AV Access Thrombectomy! ✔ No lytics ✔ 45-minute procedure time ✔ 100% technical success Read more: bit.ly/3ZfBGzv

Don Garbett (@dongarbettmd) 's Twitter Profile Photo

Austin Bourgeois Sabeen Dhand AJ Gunn Theresa M. Caridi MD, FSIR Keith Pereira MD, #VIrad Fibroids No More BackTable Vascular and Interventional 𝙍𝙖𝙠𝙚𝙨𝙝 𝙎. 𝘼𝙝𝙪𝙟𝙖, 𝙈𝘿 First DVT I saw in practice was due to iliac compression from a huge fibroid uterus. We treated with the old trellis device and the patient had hysterectomy shortly after. I’ve moved to getting cross sectional imaging on all my patients with DVT extending above the femoral vein.

Inari Medical (@inarimedical) 's Twitter Profile Photo

Another Revcore thrombectomy catheter first! A multicenter and retrospective study of deep-vein in-stent thrombosis showed intervention with #RevCore safely re-established and sustained patency across a variety of venous stent types. Thank you to the investigators Drs.

Inari Medical (@inarimedical) 's Twitter Profile Photo

Today we celebrate Jason Palmer, Mike Brege, Mike Markoski, Ray Fulkerson, Bill Rosenstihl, Tien Nguyen, Robb Lombardi, Steve Kuders, and Nick Agostinelli who have each touched the lives of more than 1,000 patients. Our commitment to providing patients with the best possible care

Today we celebrate Jason Palmer, Mike Brege, Mike Markoski, Ray Fulkerson, Bill Rosenstihl, Tien Nguyen, Robb Lombardi, Steve Kuders, and Nick Agostinelli who have each touched the lives of more than 1,000 patients. Our commitment to providing patients with the best possible care
Inari Medical (@inarimedical) 's Twitter Profile Photo

Myles’ life changed instantly when a fall from an 11-meter structure left him with numerous life-threatening injuries. Among these life-threatening injuries, the most serious was Myles' detached IVC. As he recovered, an even greater challenge emerged: a massive, chronic

Inari Medical (@inarimedical) 's Twitter Profile Photo

We're just ONE day away from #PEERLESS, a Randomized Controlled Trial (RCT) of FlowTriever vs. catheter-directed thrombolytics (CDT) in #pulmonaryembolism. Don't miss the late-breaking results during #TCT2024 tomorrow! Cardiovascular Research Foundation TCT Conference Wissam A Jaber

Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI (@drjaymohan) 's Twitter Profile Photo

1/ Ilofem DVT- valve function RESTORED post thrombectomy ❓Thoughts- I get asked a lot about concern for valve damage post thrombectomy. Here’s a great case demonstrating preservation. It’s the clot that destroys the valve. The longer it’s there the most destruction occurs

Inari Medical (@inarimedical) 's Twitter Profile Photo

What a week at #TCT2024! Thank you to everyone who joined us at the booth and those who listened in as Dr. Wissam A Jaber presented the positive results from the #PEERLESS RCT during the Late-Breaking Clinical Trial Session! We appreciated the insights shared by Drs. Wissam A Jaber ,

Venous News (@venousnews) 's Twitter Profile Photo

#VIVA24: David Dexter reports complete two-year outcomes from the CLOUT (ClotTriever) registry: 81.5% of treated limbs had no post-thrombotic syndrome compared to 18.8% at baseline; the prevalence of moderate or severe PTS was 6.4% compared to 46.9% at baseline. The VIVA Foundation

#VIVA24: David Dexter reports complete two-year outcomes from the CLOUT (ClotTriever) registry: 81.5% of treated limbs had no post-thrombotic syndrome compared to 18.8% at baseline; the prevalence of moderate or severe PTS was 6.4% compared to 46.9% at baseline. <a href="/VIVAPhysicians/">The VIVA Foundation</a>
Inari Medical (@inarimedical) 's Twitter Profile Photo

We’re pleased to announce the completion of Stryker’s acquisition of Inari Medical. By coming together, we will make a greater impact on patients around the world. Thank you to our incredible team and partners as we begin this exciting next chapter! Read more in the press

We’re pleased to announce the completion of Stryker’s acquisition of Inari Medical. By coming together, we will make a greater impact on patients around the world.

Thank you to our incredible team and partners as we begin this exciting next chapter!

Read more in the press
Adam Schefter (@adamschefter) 's Twitter Profile Photo

Through three rounds, five quarterbacks now have been drafted. But when the fourth round opens Saturday, Colorado quarterback Shedeur Sanders will be the biggest name available after what has been an unprecedented draft fall.

The New Republican Colorado (@newrepublicanco) 's Twitter Profile Photo

Denver: Ditch the wasteful new bike lanes that steal our parking and traffic lanes. Instead, clean up the neglected Cherry Creek and Platte River Bike trails— that’s the real win for cyclists and our city! I am Do Better Denver